Skip to main content

Table 2 Leishmania spp. Antibiogram of ATCC© and Clinical Isolates Resistant at Varying Concentrations of Amphotericin B and Fluconazole

From: Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform

Species

Total Number of Isolates

Amphotericin B (μg/mL)

Fluconazole (μg/mL)

0.12

0.25

0.5

1

≥256

Old World

L. donovani ATCC®50212™

3

3 (100%)

0 (0%)

0 (0%)

0 (0%)

3 (100%)

L. infantum ATCC®50134™

5

2 (40%)

1 (20%)

0 (0%)

0 (0%)

5 (100%)

 Clinical L. infantum

3

0 (0%)

0 (0%)

0 (0%)

0 (0%)

3 (100%)

L. tropica ATCC®50129™

3

3 (100%)

0 (0%)

0 (0%)

0 (0%)

3 (100%)

 Clinical L. tropica

6

6 (100%)

0 (0%)

0 (0%)

0 (0%)

6 (100%)

L. major ATCC®50122™

4

4 (100%)

3 (75%)

0 (0%)

0 (0%)

4 (100%)

New World

L. amazonensis ATCC®50159™

3

3 (100%)

2 (66.6%)

1 (33.3%)

0 (0%)

3 (100%)

L. chagasi ATCC®50133™

3

3 (100%)

1 (33.3%)

0 (0%)

0 (0%)

3 (100%)

L. mexicana ATCC®50157™

3

3 (100%)

1 (33.3%)

0 (0%)

0 (0%)

3 (100%)

L. V. braziliensis ATCC® 50135™

3

3 (100%)

0 (0%)

0 (0%)

0 (0%)

3 (100%)

 Clinical L. V. braziliensis

3

3 (100%)

3 (100%)

0 (0%)

0 (0%)

3 (100%)

L. V. guyanensis ATCC®50126™

4

2 (50%)

1 (25%)

0 (0%)

0 (0%)

4 (100%)

L. V. panamensis ATCC®50158™

3

3 (100%)

3 (100%)

0 (0%)

0 (0%)

3 (100%)

 Clinical L. V. panamensis

15

4 (27%)

3 (25%)

1 (8.3%)

0 (0%)

15 (100%)